0001562180-22-006617.txt : 20220912
0001562180-22-006617.hdr.sgml : 20220912
20220912200354
ACCESSION NUMBER: 0001562180-22-006617
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220908
FILED AS OF DATE: 20220912
DATE AS OF CHANGE: 20220912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Woock John
CENTRAL INDEX KEY: 0001756437
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38721
FILM NUMBER: 221239567
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axonics, Inc.
CENTRAL INDEX KEY: 0001603756
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 454744083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-396-6322
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Axonics Modulation Technologies, Inc.
DATE OF NAME CHANGE: 20140326
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-09-08
false
0001603756
Axonics, Inc.
AXNX
0001756437
Woock John
26 TECHNOLOGY DRIVE
IRVINE
CA
92618
false
true
false
false
Chief Marketing Officer
Common Stock
2022-09-08
4
M
false
3800.00
1.42
A
49776.00
D
Common Stock
2022-09-08
4
S
false
3800.00
75.0063
D
45976.00
D
Common Stock
2022-09-08
4
M
false
3700.00
1.63
A
49676.00
D
Common Stock
2022-09-08
4
S
false
3700.00
75.00
D
45976.00
D
Stock Option (Right to Buy)
1.63
2022-09-08
4
M
false
3700.00
0.00
D
2028-03-30
Common Stock
3700.00
0.00
D
Stock Option (Right to Buy)
1.42
2022-09-08
4
M
false
3800.00
0.00
D
2027-08-25
Common Stock
3800.00
378.00
D
This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
This transaction was executed in multiple trades at prices ranging from $75.00 to $75.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The shares subject to the option vest over a period of four years. 7,800 of the shares subject to the option vested on March 30, 2018 and the remainder vest at a rate of 1/36th per month commencing on March 30, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
The shares subject to the option vest over a period of four years. 3,545 of the shares subject to the option vested on July 21, 2017 and the remainder vest at a rate of 1/36th per month commencing on July 21 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
/s/ Dan Dearen, as Attorney-in-Fact for John Woock, Ph.D
2022-09-12